Share on StockTwits
 

Insulet Corp. (NASDAQ:PODD) is set to release its Q413 earnings data on Thursday, February 27th. Analysts expect Insulet Corp. to post earnings of ($0.09) per share and revenue of $67.94 million for the quarter.

Shares of Insulet Corp. (NASDAQ:PODD) opened at 45.74 on Wednesday. Insulet Corp. has a one year low of $20.87 and a one year high of $46.21. The stock has a 50-day moving average of $41.93 and a 200-day moving average of $37.61. The company’s market cap is $2.495 billion.

PODD has been the subject of a number of recent research reports. Analysts at Feltl & Co. downgraded shares of Insulet Corp. from a “hold” rating to a “sell” rating in a research note on Friday, February 21st. They now have a $33.00 price target on the stock. On the ratings front, analysts at Canaccord Genuity raised their price target on shares of Insulet Corp. from $45.00 to $53.00 in a research note on Friday, January 24th. They now have a “buy” rating on the stock. Finally, analysts at Zacks downgraded shares of Insulet Corp. from a “neutral” rating to an “underperform” rating in a research note on Monday, January 13th. They now have a $34.40 price target on the stock. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $37.95.

Insulet Corporation is primarily engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (NASDAQ:PODD).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.